Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
Condition(s):COVID-19; COVID-19 Acute Respiratory Distress SyndromeLast Updated:May 3, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):COVID-19; COVID-19 Acute Respiratory Distress SyndromeLast Updated:May 3, 2023Not yet recruiting
Condition(s):Anxiety; Stress; Memory Deficits; Cortisol OverproductionLast Updated:November 8, 2022Completed
Condition(s):NAFLD; NASH – Nonalcoholic SteatohepatitisLast Updated:February 3, 2021Unknown status
Condition(s):Complementary Feeding; Linear Programming; Nutritional Status; Micronutrient Deficiency; Growth FailureLast Updated:March 27, 2019Completed
Condition(s):Autism Spectrum Disorder; Phelan-McDermid SyndromeLast Updated:March 18, 2020Unknown status
Condition(s):Neurocognitive Function; MoodLast Updated:March 18, 2020Completed
Condition(s):Healthy ChildrenLast Updated:November 9, 2023Completed
Condition(s):Hair LossLast Updated:May 13, 2021Completed
Condition(s):Acne; Premenstrual SyndromeLast Updated:February 22, 2024Completed
Condition(s):Micronutrient StatusLast Updated:November 14, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.